Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age? - Wikidata - awgldk - TriplyDB

Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?

Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?

http://www.wikidata.org/entity/Q37654357

about

Predictors of well-being and quality of life in men who underwent radical prostatectomy: longitudinal study1 Impact of Body Mass Index on Oncological Outcomes of Prostate Cancer Patients after Radical Prostatectomy

P2860

Q58767039-4D0BC1E1-6368-44BB-B64E-4C1EEB1A8D23 Q58790804-76B479B9-575B-401B-8875-E990C951FE49

P2860

Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?

http://www.wikidata.org/entity/Q37654357

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Are the Pathological Character ...... epending upon the Patient Age?

@en

Are the Pathological Character ...... epending upon the Patient Age?

@nl

type

label

Are the Pathological Character ...... epending upon the Patient Age?

@en

Are the Pathological Character ...... epending upon the Patient Age?

@nl

prefLabel

Are the Pathological Character ...... epending upon the Patient Age?

@en

Are the Pathological Character ...... epending upon the Patient Age?

@nl

P1433

Q37654357-626E0ACF-69B4-4783-B46B-8C78CB9CD36E

P1476

Q37654357-E114345E-F100-4A48-AA51-B1609E964E7D

P2093

Q37654357-277824FD-DCC8-4EB6-A9AC-A4F708E245AB

Q37654357-4F7223BD-CB6F-47A7-B556-E6BBC78B6A2C

Q37654357-A7792A52-07F5-4F4D-8424-1CDC0254857B

Q37654357-B56DAA3E-539F-4FDB-9352-36DA0E8142A1

Q37654357-DA57B2EB-A703-45EF-A53E-F97A403E0A10

Q37654357-E3469C01-7CD6-489E-9FB5-9E5466FC5216

Q37654357-EC86FB35-FBA0-48C9-83D5-77D45D5E1CD5

Q37654357-FB6CA714-4499-4B6A-81C6-986A725CA4B6

P2860

Q37654357-02BAD2BF-D5C2-43B7-AFE8-DDC287507427

Q37654357-0A56C129-42C7-4B76-8F5B-BFA2A35BB7D3

Q37654357-16502651-B8B6-45F5-94D3-5B42B9049EE1

Q37654357-250B7ABA-F70C-409A-9B8D-CB62BDB47389

Q37654357-2735BC61-3E9E-4BE2-9317-4814F0D5A47B

Q37654357-28D2A48D-4652-4128-AE51-348E137582EE

Q37654357-348D9B07-B002-4565-95C0-9AF8395672BE

Q37654357-39897243-1896-4D69-BCCF-23C74ED28E04

Q37654357-45BC8EDA-7945-4593-84B1-8B22C9B8D853

Q37654357-507CEEA9-3625-4E7A-81BD-5C8585D40821

P304

Q37654357-D4C26D17-0548-40C7-AC15-B7FB515D4968

P31

Q37654357-52CBD361-1CCF-4540-ABF9-9D9191739C4A

P356

Q37654357-7E40CEB8-1912-4922-9969-0F5BC2197F45

P407

Q37654357-76D85C49-72E4-4C61-9915-3E909AF85320

P478

Q37654357-55444F95-1FD2-4971-A244-C5DAE6DDBFA1

P50

Q37654357-30607EE8-FCC7-4291-BB8F-510D5AFF06E6

Q37654357-A06E046F-FB76-4020-A833-18E6FA9EBB17

Q37654357-ADA7A4AF-B00D-4009-BA08-E61E603F2E3B

P577

Q37654357-5576EE4A-DB8F-4471-90E0-38F1742424D2

P698

Q37654357-8DA690E4-3FEC-41BF-865F-6B0B71FA7A98

P932

Q37654357-142340C1-0590-43A3-AA94-B909730F9F1D

P356

P1433

BioMed Research International

P1476

Are the Pathological Character ...... epending upon the Patient Age?

@en

P2093

Cong Huang

http://www.w3.org/2001/XMLSchema#string

Dong Fang

http://www.w3.org/2001/XMLSchema#string

Guangjie Ji

http://www.w3.org/2001/XMLSchema#string

Han Hao

http://www.w3.org/2001/XMLSchema#string

He Wang

http://www.w3.org/2001/XMLSchema#string

Lin Cai

http://www.w3.org/2001/XMLSchema#string

Qun He

http://www.w3.org/2001/XMLSchema#string

Zhisong He

http://www.w3.org/2001/XMLSchema#string

P2860

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.

Cancer statistics, 2012

Germline mutations in HOXB13 and prostate-cancer risk

Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.

Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database.

Prostate cancer in young men: an important clinical entity.

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy.

Impact of age at diagnosis on prostate cancer treatment and survival

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

P304

1438027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/1438027

http://www.w3.org/2001/XMLSchema#string

P407

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28265568

http://www.w3.org/2001/XMLSchema#string

P932

5318620

http://www.w3.org/2001/XMLSchema#string